Leukemia Research Program

Leukemia Research Program Specific Aims:
  • To integrate genetic, epigenetic, RNA/protein, non-coding RNAs and biochemical features of tumor cells to enhance both risk stratification and target directed therapy for leukemia
  • To facilitate development of innovative preclinical and clinical immunotherapeutic approaches for leukemia
  • To foster pre-clinical and clinical development of  targeted therapeutics directed at leukemia relevant kinase signaling pathways

The Ohio State University Comprehensive Cancer Center – Arthur G. James Cancer Hospital and Richard J. Solove Research Institute (OSUCCC – James) 460 W. 10th Avenue, Columbus, OH 43210 Phone: 1-800-293-5066 | Email: jamesline@osumc.edu